Sign up to save your podcasts
Or
Share Ulcerative Colitis: Targeting Immunological Pathways in Moderate to Severe Disease – Updates From Copenhagen
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ulcerative Colitis: Targeting Immunological Pathways in Moderate to Severe Disease – Updates From Copenhagen
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn's disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, expert physicians will discuss investigational UC therapies with various mechanisms of action.
For the full CME activity, click here
View all episodes
By Vindico Medical Education
4.8
99 ratings
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn's disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, expert physicians will discuss investigational UC therapies with various mechanisms of action.
For the full CME activity, click here